Back to the main directory
Press Release
- neffy® approved as the first needle-free anaphylaxis treatment of adults and children in Canada by GlobeNewsWire
- Net Asset Value by GlobeNewsWire
- Comstock Releases Shareholder Letter and Reminder of AGM Registration by GlobeNewsWire
- DHT Holdings, Inc. Business Update by GlobeNewsWire
- MasterCraft Boat Holdings, Inc. to Webcast Fiscal Third Quarter 2026 Earnings Conference Call Thursday, May 7, 2026 by GlobeNewsWire
- Path2 Hydrogen und MP Industries geben strategische Partnerschaft zur Entwicklung integrierter Wasserstoffprojekte in ganz Europa bekannt by GlobeNewsWire
- Bowman Awarded $4.9 Million Contract to Lead Construction Engineering & Inspection for Major Wastewater Treatment Expansion by GlobeNewsWire
- Harvia Oyj:n varsinaisen yhtiökokouksen päätökset 15.4.2026 by GlobeNewsWire
- Orion Reiterates Expectations for Increased Growth and Profitability in FY 2026 and FY 2027; Strong Profitable Growth Drive Highlights Sally Washlow’s First Year as CEO by GlobeNewsWire
- Stereotaxis Announces Definitive Agreement to Acquire Robocath by GlobeNewsWire
- Energous Reports Continued Commercial Momentum, Expanding Fortune 10 Deployments, and a Growing Multi-Vertical Proof-of-Concept Pipeline by GlobeNewsWire
- Brunswick Exploration Drills 90.5 Meters at 1.31% Li2O at Anatacau Project by GlobeNewsWire
- CECO Environmental to Release First Quarter 2026 Earnings and Host Conference Call on April 28 by GlobeNewsWire
- NRx Pharmaceuticals Advances Robotic-Enabled Transcranial Magnetic Stimulation Combined with Neuroplastic Therapy for Military and First Responder Applications by GlobeNewsWire
- Talisker Reports Mustang Underground Face Sample Results Including 886 g/t over 0.51m within 254.5 g/t over 2.74m on 1060 Level and Defines a 60 metre Strike Length High-grade Shoot Averaging 27 g/t on the 1045 Level by GlobeNewsWire
- COURTOIS SA by GlobeNewsWire
- Medicus Pharma to Present New Teverelix Data at AACE 2026 Demonstrating Long-Acting Hormone Suppression by GlobeNewsWire
- Arbutus Receives U.S. FDA Fast Track Designation for Imdusiran for the Treatment of Chronic Hepatitis B by GlobeNewsWire
- Knight présentera à la conférence des investisseurs en santé Bloom Burton & Co. 2026 by GlobeNewsWire
- Ridgepost Capital Schedules First Quarter 2026 Earnings Release for Thursday, May 7, 2026 by GlobeNewsWire
- TG Therapeutics Announces Completion of Enrollment for the Phase 3 Trial Evaluating Subcutaneous BRIUMVI by GlobeNewsWire
- POWELL MAX LIMITED ANNOUNCES 1-FOR-10 SHARE CONSOLIDATION EFFECTIVE APRIL 17, 2026 by GlobeNewsWire
- Golden Pursuit Resources Announces the Appointment of Stacy Freudigmann, P.Eng. F.Aus.IMM as Director and COO by Newsfile Corp.
- Volatus Aerospace Secures Multi-Year Training Contract with NATO-Allied Government by GlobeNewsWire
- Teva Launches Home Ground™ Schizophrenia Community, a New Online Resource Hub for People Living with Schizophrenia and Their Care Partners by GlobeNewsWire